The molecular biologist, who is founder and president of NovaRx, mixes four different irradiated lung cancer cell lines with some DNA he has constructed, then gives the mixture several electric charges so they bind together.
The principal aim of the grant is to evaluate the molecular mechanisms and underlying pathways of tissue engineering and cell therapy for regenerating airways and lung tissue, and to carry out translational studies for the prevention and effective treatment of a wide range of diseases.